Abstract

Fe65 undergoes a phosphatase-sensitive gel mobility shift after DNA damage, consistent with protein phosphorylation. A recent study identified Ser228 as a specific site of phosphorylation, targeted by the ATM and ATR protein kinases, with phosphorylation inhibiting the Fe65-dependent transcriptional activity of the amyloid precursor protein (APP). The direct binding of Fe65 to APP not only regulates target gene expression, but also contributes to secretase-mediated processing of APP, producing cytoactive proteolytic fragments including the APP intracellular domain (AICD) and cytotoxic amyloid β (Aβ) peptides. Given that the accumulation of Aβ peptides in neural plaques is a pathological feature of Alzheimer’s disease (AD), it is essential to understand the mechanisms controlling Aβ production. This will aid in the development of potential therapeutic agents that act to limit the deleterious production of Aβ peptides. The Fe65-APP complex has transcriptional activity and the complex is regulated by multiple post-translational modifications and other protein binding partners. In the present study, we have identified Ser289 as a novel site of UV-induced phosphorylation. Interestingly, this phosphorylation was mediated by ATM, rather than ATR, and occurred independently of APP. Neither phosphorylation nor mutation of Ser289 affected the Fe65-APP interaction, though this was markedly decreased after UV treatment, with a concomitant decrease in the protein levels of APP in cells. Using mutagenesis, we demonstrated that Fe65 Ser289 phosphorylation did not affect the transcriptional activity of the Fe65-APP complex, in contrast to the previously described Ser228 site.

Highlights

  • Fe65 is an adaptor protein consisting of an N-terminal WW domain and two C-terminal phosphotyrosine binding domains (PTB1 and PTB2) [1]

  • As part of an earlier study, we identified Fe65 Ser228 as a DNA damage-induced site of phosphorylation using an anti-ATM/ATR motif antibody [raised against a library of peptides phosphorylated on Ser/Thr followed by Gln (SQ/TQ)–the ATM/ATR ‘consensus sequence’]

  • Cells were transfected with GFP-Fe65 or GFP-Fe65 S228A and Fe65 immunoprecipitated from untreated cells or UV-treated cells

Read more

Summary

Introduction

Fe65 is an adaptor protein consisting of an N-terminal WW domain and two C-terminal phosphotyrosine binding domains (PTB1 and PTB2) [1]. Fe65 regulates the secretase-mediated processing of APP [2] and formation of multiple proteolytic APP fragments, including a large extracellular fragment, the 40–42 amino acid Aβ peptide (from the APP transmembrane region) and the APP intracellular domain (AICD). Aβ has cytotoxic potential and is likely to play an important role in the neurodegenerative.

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.